FINTEPLA will be launched through a restricted distribution program, called the FINTEPLA Risk Evaluation and Mitigation Strategy (REMS) Program, and is expected to be available through Zogenix’s specialty pharmacy partner Anovo
Many medications for elderly patients need to be used with special caution because of age-related changes
AmerisourceBergen’s commercialization support services offer an integrated approach to drug launches
Lundbeck has named AllianceRx and Orsini as the only two specialty pharmacies to distribute Vyepti
Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers
Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs
UroGen has been preparing for the commercialization of Jelmyto by increasing customer awareness and discussing the high unmet need in low-grade UTUC
New digital technologies offer a different approach to capturing, analyzing and predicting patient behavior.